Use of epinephrine in the treatment of anaphylaxis

Current Opinion in Allergy and Clinical Immunology

Volumn 3, Issue 4, 2003, Pages 313-318

  Lieberman, Phil ^a  

^a Univ of Tennessee Coll of Medicine   (United States)

Author keywords

Anaphylactoid reaction; Anaphylaxis; Epinephrine

Indexed keywords

ADRENALIN;

ANAPHYLAXIS; CLINICAL PROTOCOL; DOCTOR PATIENT RELATION; DOSE RESPONSE; DRUG SAFETY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; VASTUS LATERALIS MUSCLE;

ADRENERGIC AGONISTS; ANAPHYLAXIS; EPINEPHRINE; HUMANS; INCIDENCE; INJECTIONS, INTRAMUSCULAR;

EID: 0043011496     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200308000-00013     Document Type: Review

References (65)

1. The American Academy of Pediatrics Committee on Drugs. Anaphylaxis. Pediatrics 1973; 51:136-140.
2. The Journal of Allergy and Clinical Immunology. Position statement. J Allergy Clin Immunol 1986; 77:271-273.
3. The Joint Task Force on Practice Parameters. The diagnosis and management of anaphylaxis. Position statement. J Allergy Clin Immunol 1998; 101 (Suppl):20-28.
4. World Health Organization. Position paper on allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (Suppl.):S20.
5. American Academy of Allergy, Asthma, and Immunology Board of Directors. Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts. Position statement. J Allergy Clin Immunol 1994; 93:811-812.
6. Gavalas M, Sedana A, Metcalf S. Guidelines for the management of anaphylaxis in the emergency department. J Accid Emerg Med 1998; 15:96-98.
7. Project Team of Resuscitation Council (UK). Update on the emergency medical treatment of anaphylactic reactions for first medical responders and for community nurses. Emerg Med J 2001; 18:393-395.
8. International Guidelines 2000 for CPR and ECC. A consensus on science. Part 8: Advanced challenges in resuscitation. Section 8: Special challenges in ECC. 3D: Anaphylaxis. Resuscitation 2000; 46:285-288.
9. American Academy of Allergy, Asthma, and Immunology Board of Directors. Anaphylaxis in schools and other child care settings. J Allergy Clin Immunol 1998; 101 (Suppl.):S465-S528.
10. Canadian Pediatric Society Allergy Section. Fatal anaphylactic reactions to food in children. Position statement. Can Med Assoc J 1994; 150:337-339.
11. Brown AFT. Anaphylaxis: quintessence, quarrels, and quandaries. Emerg Med J 2001; 18:328.
12. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists. In: Hardaman JG, Limbird LE, editors. Goodman and Gilman's, the Pharmacologic basis of therapeutics, ed. 9. New York, NY: McGraw-Hill, Health Professions Division; 1996. pp. 205-209.
13. Gu X, Simons FER, Simons KJ. Epinephrine absorption after different routes of administration in an animal model. Biopharm Drug Disp 1999; 20:401-405.
14. Simons FER, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101:33-37.
15. Simons KJ, Gu X, Johnston LM, et al. Epinephrine absorption after intramuscular and subcutaneous injection in adults [Abstract]. J Allergy Clin Immunol 2001; 107:S58.
16. Ellis AK, Day JH. The role of epinephrine in the treatment of anaphylaxis. Curr Allergy Asthma Rep 2003; 3:11-14. A recent brief review of the use of epinephrine in the treatment of anaphylaxis.
17. Butte MJ, Nguyen BX, Hutchison TJ, et al. Pediatric myocardial infarction after racemic epinephrine administration. Pediatrics 1999; 104:9-11
18. Saff R, Nahhas A, Fink JN. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine. Ann Allergy 1993; 70:396-398.
19. Davis CO, Wax PM. Pre-hospital epinephrine overdose in a child resulting from ventricular dysrhythmias and myocardial ischemia. Pediatr Emerg Care 1999; 15:116-118.
20. Ackerman MJ, Khositseth A, Tester D, et al. Epinephrine induced QT interval prolongation: a gene specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77:413-421. This study intended to discuss the use of epinephrine testing for the detection of latent prolonged QT intervals, but also contains a nice discussion regarding the effect of the arrhythmogenic effects of epinephrine.
21. Toogood JH. Beta-blocker therapy and the risk of anaphylaxis. Can Med Assoc J 1987; 136:929-933.
22. Hart LL, Sue D. Potentiated anaphylaxis during chronic beta-blocker therapy. Drug Intell Clin Pharm 1988; 22:720-721.
23. Kivity S, Yarchovsky J. Relapsing anaphylaxis to bee sting in a patient treated with beta-blocker and Ca blocker. J Allergy Clin Immunol 1990; 85:669-670.
24. Newman BR, Schultz LK. Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride. Ann Allergy 1981; 47:35-37.
25. Raebel MA. Potentiated anaphylaxis during chronic beta-blocker therapy. Drug Intell Clin Pharm 1988; 22:720-727.
26. Physician's desk reference, Edition 56. 2002; p. 1608, p. 3117.
27. Coghlan-Johnston M, Lieberman P. Demographic and clinical characteristics of anaphylaxis [Abstract]. J Allergy Clin Immunol 2001; 107:S57.
28. Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis, a review of 266 cases. Arch Intern Med 1995; 155:1749-1754.
29. Sicherer SH, Forman JA, Noone SA. Use assessed in self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000; 105:359-362.
30. Grouhi M, Alshehri M, Hummel D, Roifman CM. Anaphylaxis and epinephrine autoinjector training: who will teach the teachers? J Allergy Clin Immunol 1999; 104:190-193.
31. Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol 2000; 106:171-176.
32. Hutcheson PS, Slavin RG. Lack of preventive measures given to patients with stinging insect anaphylaxis in hospital emergency rooms. Ann Allergy 1990; 64:306-307.
33. Rotskoff BD, Greenberger PA, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated co-morbid disease [Abstract]. J Allergy Clin Immunol 2003; 111:S101.
34. Friesen JH, Morchen S, Kelly CS, Hogan AD. Comparison of pediatric and adult anaphylaxis cases presenting to emergency departments [Abstract]. J Allergy Clin Immunol 2003; 111:S101.
35. Dily DJ, Roberts JR. Why do parents not use EpiPens when children experience anaphylaxis? [Abstract]. J Allergy Clin Immunol 2003; 111:S101.
36. Dunn JM and DeMasi JM. Anaphylaxis in the school setting [Abstract]. J Allergy Clin Immunol 2003; 111:S121.
37. Friesen J, Morchen S, Kelly C, Hogan A. Systemic allergic reactions in a pediatric ER in Southeastern Virginia [Abstract]. J Allergy Clin Immunol 2002; 109:S180.
38. Zukerman G, McCluskey B, Boozan J, et al. Attitudes, experience, and expertise of emergency medical technicians (EMTs) regarding the use of epinephrine autoinjectors [Abstract]. J Allergy Clin Immunol 2002; 109:S181.
39. Mehra S, Salter J, Sussman G, et al. A study of 32 food-related deaths from anaphylaxis: Ontario; 1986-2000 [Abstract]. J Allergy Clin Immunol 2002; 109:S181.
40. Clark S, Kamarthi G, Okafo T, et al. Multi-center study of emergency department visits for bee sting allergy [Abstract]. J Allergy Clin Immunol 2002; 109:S270.
41. Salter J, Mehra S, Cairns J, Vadis P. Insect sting related deaths in Ontario 1986-2000 [Abstract]. J Allergy Clin Immunol 2002; 109:S269.
42. Demera RS, Teuber S. Failure to prescribe epinephrine in systemic allergic reactions [Abstract]. J Allergy Clin Immunol 2001; 107:S59.
43. Osuchukwu C, Alfaham M, Ramgaraj S. Parental questionnaire on EpiPen provision, education and subsequent usage [Abstract]. J Allergy Clin Immunol 2001; 107:S272.
44. Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144-1150.
45. Goldberg A, Confino-Cohen R. Insect sting inflicted systemic reactions: attitudes of patients with insect venom allergy regarding after sting behavior and proper administration of epinephrine. J Allergy Clin Immunol 2000; 106:1184-1189.
46. Gompels LL, Bethune C, Johnston SL, Gompels MM. Proposed dose of adrenaline (epinephrine) in anaphylaxis and related conditions: a study of senior house officers starting accident and emergency posts. Postgrad Med J 2002; 78:416-418. Senior house officers beginning their service in accident and emergency posts were asked to complete questionnaires regarding five case histories. Only a small minority were knowledgeable regarding the route and dose of epinephrine administration as outlined in Resuscitation Council guidelines (see ref. [7]).
47. Simons FER, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr. autoinjectors: past their prime? J Allergy Clin Immunol 2000; 105:1025-1030.
48. Simons FER, Peterson S, Black C. Epinephrine dispensing for out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Ann Allergy Asthma Immunol 2001; 86:622-626.
49. Sicherer SH. Self-injected epinephrine: no size fits all. Ann Allergy Asthma Immunol 2001; 86:597-598.
50. Bock SA, Munoz-Furlong A, Sampson H. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191-193.
51. Bautista E, Simons FE, Simons KJ, et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002; 128:151-164. A unique study designed to reveal whether epinephrine is effective by any route during the nadir of full-blown anaphylactic shock.
52. Smith P, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072-1080.
53. Lieberman P. Anaphylaxis and anaphylactoid reactions. In: Middleton E, Ellis E, Yunginger J, Reed C, Adkinson A, Busse W, editors. Allergy: principles and practice, 6th ed. St Louis, Missouri: Mosby-Year Book, Inc.; (in press).
54. Simons FER, Chan ES, Gu S, Simons KJ. Epinephrine for the out-of-hospital (first aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical? J Allergy Clin Immunol 2001; 108:1040-1044.
55. Barach EM, Nowak BM, Lee TG, et al. Epinephrine for treatment of anaphylactic shock. JAMA 1984; 251:2118-2122.
56. Levy JH, Levi R. Diagnosis and treatment of anaphylactic/anaphylactoid reactions. In: Assem E-SK, editor. Allergic reactions to anaesthetics: clinical and basic aspects. Monogr Allergy 1992; 30:130-144.
57. Fath JJ, Cerra FB. The therapy of anaphylactic shock. Drug Intell Clin Pharm 1984; 18:14-21.
58. Saryan JA, O'Loughlin JM. Anaphylaxis in children. Pediatr Ann 1992; 21:590-598.
59. Ewan PW, Clark AT. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 2001; 357:111-115.
60. Mellem H, Lande K, Kjeldsen SE, et al. Faster and more reliable absorption of adrenaline by aerosol inhalation than by subcutaneous injection. Br J Clin Pharmacol 1991; 31:677-681.
61. Simons FER, Gu Xiaochen, Johnston LM, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics 2000; 106:1040-1044.
62. Gu X, Simons KJ, Simons FER. Is epinephrine administration from a sublingual tablet feasible for the out-of-hospital first aid treatment of anaphylaxis? Absorption studies in an animal model [Abstract]. J Allergy Clin Immunol 2002; 109:788.
63. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002; 110:647-651.
64. Rangaraj S, Tathill D, Burr M, Llandough M. Childhood epidemiology of anaphylaxis and epinephrine prescriptions in Wales: 1994-1999 [Abstract]. J Allergy Clin Immunol 2002; 109:S75.
65. Simons FER, Chad ZH, Gold M. Real-time reporting of anaphylaxis in infants, children and adolescents by physicians involved in the Canadian Pediatric Surveillance Program [Abstract]. J Allergy Clin Immunol 2002; 109:S181.